Automatic cyst and kidney segmentation in autosomal dominant polycystic kidney disease: Comparison of U-Net based

Maria Rombolotti1, Fabio Sangalli2, Domenico Cerullo3

  • 1Department of Mathematics, Politecnico di Milano, Milan, Italy.

Insights

We developed an automated U-Net based deep learning method for segmenting kidney and cysts in micro-CT images. This approach accurately quantifies disease progression in Autosomal Dominant Polycystic Kidney Disease models.

Area of Science:

  • Medical Imaging
  • Biomedical Engineering
  • Computational Biology

Background:

  • Autosomal Dominant Polycystic Kidney Disease (ADPKD) causes kidney cysts, leading to renal failure.
  • Accurate quantification of kidney and cyst volume is crucial for drug development in ADPKD models.
  • Current segmentation methods for micro-CT images can be slow and lack reproducibility.

Purpose of the Study:

  • To develop and compare fully convolutional networks for automated kidney and cyst segmentation in micro-CT images.
  • To evaluate the performance of U-Net based architectures for ADPKD research.
  • To provide a fast and reproducible method for analyzing renal morphology in disease models.

Main Methods:

  • Implementation of U-Net architectures with variations (batch normalization, inception blocks) for image segmentation.
  • Testing networks on contrast-enhanced micro-CT images from normal and ADPKD rat models.
  • Evaluation using Intersection over Union (IoU) and Dice similarity coefficients.

Main Results:

  • U-Net with batch normalization and U-Net with inception blocks demonstrated superior performance.
  • Accurate cyst-to-kidney volume ratios were obtained, a key metric for ADPKD progression.
  • Segmentation performance remained stable despite variations in the training dataset.

Conclusions:

  • The proposed automated segmentation methodology is effective and applicable for micro-CT image analysis in ADPKD.
  • This method provides direct and accurate cyst-to-kidney volume ratios, aiding research.
  • The U-Net based approach offers a reliable tool for preclinical ADPKD drug discovery.